Patents by Inventor Aikaterini Lalatsa

Aikaterini Lalatsa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210038730
    Abstract: a nanofiber comprising a peptide GPCR modulator conjugated to a lipophilic moiety where in the peptide-lipophilic moiety conjugate comprises a poly(proline) type II helix structure.
    Type: Application
    Filed: April 2, 2019
    Publication date: February 11, 2021
    Inventors: Aikaterini LALATSA, Diane LEITE
  • Patent number: 8920819
    Abstract: Compositions comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy of the human or animal body are provided. Methods of medical treatment, wherein a composition according to the invention is administered to a human or animal body also form part of the invention. It is preferred that the drug is delivered to the brain.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: December 30, 2014
    Assignee: University College London
    Inventors: Ijeoma Uchegbu, Aikaterini Lalatsa, Andreas Schatzlein
  • Publication number: 20130034590
    Abstract: Compositions comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy of the human or animal body are provided. Methods of medical treatment, wherein a composition according to the invention is administered to a human or animal body also form part of the invention. It is preferred that the drug is delivered to the brain.
    Type: Application
    Filed: August 31, 2012
    Publication date: February 7, 2013
    Inventors: Ijeoma Uchegbu, Aikaterini Lalatsa, Andreas Schatzlein
  • Patent number: 8278277
    Abstract: Compositions comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy of the human or animal body are provided. Methods of medical treatment, wherein a composition according to the invention is administered to a human or animal body also form part of the invention. It is preferred that the drug is delivered to the brain.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: October 2, 2012
    Assignee: University College London
    Inventors: Ijeoma Uchegbu, Aikaterini Lalatsa, Andreas Schatzlein
  • Publication number: 20100222281
    Abstract: Compositions comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy of the human or animal body are provided. Methods of medical treatment, wherein a composition according to the invention is administered to a human or animal body also form part of the invention. It is preferred that the drug is delivered to the brain.
    Type: Application
    Filed: April 9, 2009
    Publication date: September 2, 2010
    Applicant: SCHOOL OF PHARMACY, UNIVERSITY OF LONDON
    Inventors: Ijeoma Uchegbu, Aikaterini Lalatsa, Andreas Schatzlein